Related references
Note: Only part of the references are listed.Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis
Robert C. Wirka et al.
NATURE MEDICINE (2019)
Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
Ingrid Gergei et al.
ATHEROSCLEROSIS (2019)
Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis
S. -C Bae et al.
LUPUS (2019)
Single-cell immune landscape of human atherosclerotic plaques
Dawn M. Fernandez et al.
NATURE MEDICINE (2019)
Pulse Wave Velocity in Atherosclerosis
Hack-Lyoung Kim et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis
Tom T. P. Seijkens et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The relationship between soluble CD40 ligand level and atherosclerosis in white-coat hypertension
Yu-qing Huang et al.
JOURNAL OF HUMAN HYPERTENSION (2017)
Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study
A. C. Shore et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Inflammation and plaque vulnerability
G. K. Hansson et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Increased circulating soluble CD40 levels in patients with slow coronary flow phenomenon: an observational study
Murtaza Emre Durakoglugil et al.
ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY (2013)
Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques
Giuseppe Asciutto et al.
CARDIOVASCULAR PATHOLOGY (2013)
Pathophysiology of Atherosclerosis Plaque Progression
Kenichi Sakakura et al.
HEART LUNG AND CIRCULATION (2013)
Levels of sCD40 Ligand in Chronic and Acute Coronary Syndromes and its Relation to Angiographic Extent of Coronary Arterial Narrowing
Hanan H. Fouad et al.
ANGIOLOGY (2010)
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
Esther Lutgens et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease
M. B. I. Lobbes et al.
ATHEROSCLEROSIS (2006)
Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease
Jozsef Balla et al.
DISEASE MARKERS (2006)
The relationship between soluble CD40 ligand levels and Framingham coronary heart disease risk score in healthy volunteers
S Verma et al.
ATHEROSCLEROSIS (2005)
CD40 ligation activates murine macrophages via an IFN-γ-dependent mechanism resulting in tumor cell destruction in vitro
IN Buhtoiarov et al.
JOURNAL OF IMMUNOLOGY (2005)
Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients
C Contin et al.
IMMUNOLOGY (2003)
Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischernic stroke - A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke
JK Cha et al.
CEREBROVASCULAR DISEASES (2003)
CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1
AR Companjen et al.
INTERNATIONAL IMMUNOLOGY (2002)
Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia
CD Garlichs et al.
CIRCULATION (2001)
Soluble CD40L and cardiovascular risk in women
U Schönbeck et al.
CIRCULATION (2001)
Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype
E Lutgens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
